|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Endothelial function as an end-point in interventional trial: concepts, methods and current data 显示文摘 | Luscher TF Noll G | 1996 | J Hypertension1996，14，2： | 1 |
| 2 | Diabetes and vascular disease:pathophysiology,clinical consequences,and medical therapy:part Ⅱ显示文摘 | LUSCHER T F CREAGER M A BECKMAN J A | 2003 | Circulation2003，108，13： | 1 |
| 3 | Endothelin and cardiac arrhythmias:Do endothelinantagonists have a therapeutic potential as antiarrhythmic drugs?显示文摘 | Duru F Barton M Luscher TF | 2001 | Cardiovasc Res2001，49，： | 1 |
| 4 | Diabetes and vascular disease pathophysiology,clinical consequences and medical therapy:Part Ⅰ显示文摘 | Creager MA Luscher TF | 2003 | Circulation2003，108，： | 1 |
| 5 | Elevated atmospheric CO2, fine roots and the response of soil microorganisms: a review and hypothesis显示文摘 | Zak D R Pregiter U A Luscher A | 2000 | New Phytologist2000，147，： | 1 |
| 6 | Perindopril-function of the endothelium in coronary artery disease trial: the PER- FECT study-substudy of EUROPA: rationale and design 显示文摘 | Bots ML Remme WJ Luscher TF | 2002 | 16 (3):227-2362002，16，3： | 1 |
| 7 | Endothelial dysfunction in diabetes melli- tus 显示文摘 | Cosenfino F Luscher TF | 1998 | J Cardio Vasc Pharmocol1998，32，3： | 1 |
| 8 | Regulation of the transcription factor FOXMlc by Cyclin E/CDK2 显示文摘 | Luscher - Firzlaff JM Lilischkis R Luscher B | 2006 | FEBS Lett2006，580，7： | 1 |
| 9 | Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications显示文摘 | Luscher T F Steffel J Eberli F R | 2007 | Circulation2007，115，8： | 1 |
| 10 | Detection of shigellae, enteroinvasive and enterotoxigenic Escherichia coil using the polymerase chain reaction (PCR) in patients returning from tropical countries 显示文摘 | Luscher D Ahwegg M | 1994 | Mol Cell Probes1994，8，4： | 1 |
| 11 | Molecular and cellular mechanisms of atherosclerosis显示文摘 | Oemar BS Yang Z Luscher TF | 1995 | Curr Opin Nephrol Hypertens1995，4，： | 1 |
| 12 | Diabetes and vascular disease pathophysiology,clinical consequences and medical therapy:Part Ⅱ显示文摘 | Creager MA Luscher TF | 2003 | Circulation2003，108，： | 1 |
| 13 | Diabetes and vascular disease:pathophysiology ,clinical consequences ,and medical therapy: Part Ⅰ显示文摘 | Creager MA Luscher TF Cosentino F | 2003 | Circulation2003，108，12： | 1 |
| 14 | The ins and outs of MYC regulation by posttranslational mechanisms显示文摘 | Vervoorts J Luscher-Firzlaff J Luscher B | 2006 | J Biol Chem2006，281，34： | 1 |
| 15 | 'Endothelial progenitor cells' as a therapeutic strategy in cardiovascular disease显示文摘 | Krankel N Luscher TF Landmesser U | 2012 | Current Vascular Pharmacology2012，10，1： | 1 |
| 16 | Darusentan:a new perspective for treatment of resistant hypertension显示文摘 | Enseleit F Luscher TF Ruschitzka F | 2008 | Expert Opin Investig Drugs2008，17，8： | 1 |
| 17 | Changes in weight of the pharyngeal glandand haemolymph titres of juvenile hormone, protein and vitellogenin in worker honey bees 显示文摘 | Fluri P Luscher M Wille H Gerig L | 1992 | Journal of Insect Physiology1992，28，： | 1 |
| 18 | The GABAergic deficit hypothesis ofmajor depressive disorder显示文摘 | Luscher B Shen Q Sahir N | 2011 | Mol Psychiatry ^2011，16，4： | 1 |
| 19 | Sequence of β2-microglobulin from rhesus macaque (Macaca mulatta) includes an allelic variation in the 3'-untranslated region 显示文摘 | Su J Luscher M A MacDonald K S | 2004 | Immunogenetics2004，55，： | 1 |
| 20 | 'Pheromones':a new term for a class of biologically active substances显示文摘 | Karlson P M Luscher | 1959 | Nature1959，183，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员